Nanoparticle-Protein Interaction: Demystifying the Correlation between Protein Corona and Aggregation Phenomena.
Larissa Fernanda Ferreira1,2, Agustín Silvio Picco3, Flávia Elisa Galdino1,4
1Brazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM), 13083-970 Campinas, Brazil.
ACS Applied Materials & Interfaces
|June 13, 2022
Summary
This study introduces a multitechnique method to differentiate protein corona formation from nanoparticle aggregation. This advance is crucial for developing targeted delivery and personalized nanomedicine.
Area of Science:
- Nanotechnology
- Biomaterials Science
- Analytical Chemistry
Background:
- Protein corona formation and nanoparticle aggregation are critical challenges in nanomedicine.
- Understanding these phenomena is essential for advancing targeted drug delivery and personalized nanomedicine.
- Current methods struggle to precisely differentiate between protein corona and aggregation.
Purpose of the Study:
- To develop and validate a multitechnique approach for distinguishing protein corona from nanoparticle aggregates.
- To characterize the formation of protein corona and aggregates under varying conditions.
- To provide a reliable method for quality control in nanomedicine research.
Main Methods:
- Utilized a combination of dynamic light scattering (DLS), small-angle X-ray scattering (SAXS), and cryotransmission electron microscopy (cryo-TEM).
- Tested the methodology with model silica nanoparticles incubated with model proteins and biological proteomes (fetal bovine serum, human plasma).
- Investigated particle-protein interactions in buffers of varying ionic strengths to control interactions.
Main Results:
- Successfully differentiated between protein corona, small aggregates, and massive aggregation.
- Obtained reliable fractal information on nanoparticle aggregates.
- Demonstrated the method's efficacy across different protein sources and buffer conditions.
Conclusions:
- The presented multitechnique strategy reliably distinguishes protein corona from nanoparticle aggregation.
- This approach offers a robust platform for analyzing nanoparticle-biomolecule interactions.
- The methodology can be expanded for quality control of samples in biological testing and nanomedicine development.


